24 versus 48 Weeks of Peginterferon Plus Ribavirin in Hepatitis C Virus Genotype 6 Chronically Infected Patients with a Rapid Virological Response: A Non-Inferiority Randomized Controlled Trial

OBJECTIVES: The optimal treatment of hepatitis C virus (HCV) genotype 6 is unclear owing to its limited geographic distribution. Because of a high predictive value of rapid virological response (RVR) for sustained virological response (SVR), we conducted an open-label randomized controlled trial to...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Qingxian, Zhang, Xiaohong, Lin, Chaoshuang, Shao, Xiaoqiong, Guan, Yujuan, Deng, Hong, Wei, Min, Huang, Mingshou, Ren, Zefang, Lu, Ling, Mei, Yongyu, Xu, Min, Zhu, Jianyun, Shi, Haiyan, Lin, Guoli, Liu, Ying, Hu, Fengyu, Luo, Qiumin, Lan, Yun, Guo, Fengxia, Zhao, Zhixin, Gao, Zhiliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624894/
https://www.ncbi.nlm.nih.gov/pubmed/26509605
http://dx.doi.org/10.1371/journal.pone.0140853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624894/
https://www.ncbi.nlm.nih.gov/pubmed/26509605
http://dx.doi.org/10.1371/journal.pone.0140853

Ejemplares similares